Annual Current Liabilities
$16.82 M
+$2.66 M+18.77%
31 December 2022
Summary:
Catalyst Biosciences annual total current liabilities is currently $16.82 million, with the most recent change of +$2.66 million (+18.77%) on 31 December 2022. During the last 3 years, it has risen by +$2.66 million (+18.77%).CBIO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$1.78 M
-$1.01 M-36.16%
30 September 2023
Summary:
Catalyst Biosciences quarterly total current liabilities is currently $1.78 million, with the most recent change of -$1.01 million (-36.16%) on 30 September 2023.CBIO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CBIO Current Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | +18.8% | -87.4% |
5 y5 years | -41.8% | -93.8% |
CBIO Current Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | ||||
5 y | 5 years | ||||
alltime | all time | -83.4% | -98.2% |
Catalyst Biosciences Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2023 | - | $1.78 M(-36.2%) |
June 2023 | - | $2.79 M(-59.2%) |
Mar 2023 | - | $6.84 M(-59.3%) |
Dec 2022 | $16.82 M(+18.8%) | $16.82 M(+923.4%) |
Sept 2022 | - | $1.64 M(-61.9%) |
June 2022 | - | $4.31 M(-67.3%) |
Mar 2022 | - | $13.19 M(-6.9%) |
Dec 2021 | $14.16 M(-20.4%) | $14.16 M(-17.9%) |
Sept 2021 | - | $17.25 M(+10.8%) |
June 2021 | - | $15.57 M(+9.8%) |
Mar 2021 | - | $14.18 M(-20.3%) |
Dec 2020 | $17.80 M(-38.4%) | $17.80 M(+5.8%) |
Sept 2020 | - | $16.82 M(+23.1%) |
June 2020 | - | $13.66 M(+15.3%) |
Mar 2020 | - | $11.85 M(-59.0%) |
Dec 2019 | $28.90 M(+501.9%) | $28.90 M(+218.4%) |
Sept 2019 | - | $9.08 M(+46.5%) |
June 2019 | - | $6.20 M(+41.8%) |
Mar 2019 | - | $4.37 M(-9.0%) |
Dec 2018 | $4.80 M(-45.1%) | $4.80 M(+45.3%) |
Sept 2018 | - | $3.30 M(+35.5%) |
June 2018 | - | $2.44 M(-15.9%) |
Mar 2018 | - | $2.90 M(-66.8%) |
Dec 2017 | $8.74 M(-60.2%) | $8.74 M(-8.1%) |
Sept 2017 | - | $9.51 M(+2.4%) |
June 2017 | - | $9.28 M(-39.0%) |
Mar 2017 | - | $15.22 M(-30.7%) |
Dec 2016 | $21.96 M(-41.8%) | $21.96 M(-31.3%) |
Sept 2016 | - | $31.99 M(-4.9%) |
June 2016 | - | $33.63 M(+0.9%) |
Mar 2016 | - | $33.33 M(-11.7%) |
Dec 2015 | $37.76 M(+1195.7%) | $37.76 M(-0.4%) |
Sept 2015 | - | $37.91 M(+2207.1%) |
June 2015 | - | $1.64 M(-57.9%) |
Mar 2015 | - | $3.90 M(+33.9%) |
Dec 2014 | $2.91 M | $2.91 M(-9.3%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2014 | - | $3.21 M(-57.2%) |
June 2014 | - | $7.50 M(-24.0%) |
Mar 2014 | - | $9.87 M(-10.1%) |
Dec 2013 | $10.98 M(-3.3%) | $10.98 M(+3.2%) |
Sept 2013 | - | $10.64 M(+23.6%) |
June 2013 | - | $8.61 M(+2.8%) |
Mar 2013 | - | $8.37 M(-26.2%) |
Dec 2012 | $11.35 M(-85.6%) | $11.35 M(+15.7%) |
Sept 2012 | - | $9.81 M(-25.0%) |
June 2012 | - | $13.07 M(-72.9%) |
Mar 2012 | - | $48.20 M(-38.7%) |
Dec 2011 | $78.61 M(-20.3%) | $78.61 M(-16.0%) |
Sept 2011 | - | $93.58 M(+5.1%) |
June 2011 | - | $89.06 M(-4.6%) |
Mar 2011 | - | $93.35 M(-5.4%) |
Dec 2010 | $98.66 M(-2.5%) | $98.66 M(+3.0%) |
Sept 2010 | - | $95.80 M(-0.5%) |
June 2010 | - | $96.27 M(+13.3%) |
Mar 2010 | - | $84.94 M(-16.1%) |
Dec 2009 | $101.23 M(+634.0%) | $101.23 M(+647.6%) |
Sept 2009 | - | $13.54 M(+5.7%) |
June 2009 | - | $12.81 M(+4.5%) |
Mar 2009 | - | $12.26 M(-11.1%) |
Dec 2008 | $13.79 M(-9.2%) | $13.79 M(-3.1%) |
Sept 2008 | - | $14.23 M(+1.0%) |
June 2008 | - | $14.09 M(+3.6%) |
Mar 2008 | - | $13.59 M(-10.5%) |
Dec 2007 | $15.20 M(+69.8%) | $15.20 M(+29.5%) |
Sept 2007 | - | $11.73 M(+40.1%) |
June 2007 | - | $8.37 M(+24.8%) |
Mar 2007 | - | $6.71 M(-25.1%) |
Dec 2006 | $8.95 M(+71.8%) | $8.95 M(+23.8%) |
Sept 2006 | - | $7.23 M(+7.2%) |
June 2006 | - | $6.74 M(+30.5%) |
Mar 2006 | - | $5.17 M(-0.8%) |
Dec 2005 | $5.21 M(-1.9%) | $5.21 M |
Dec 2004 | $5.31 M | - |
FAQ
- What is Catalyst Biosciences annual total current liabilities?
- What is the all time high annual current liabilities for Catalyst Biosciences?
- What is Catalyst Biosciences quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Catalyst Biosciences?
What is Catalyst Biosciences annual total current liabilities?
The current annual current liabilities of CBIO is $16.82 M
What is the all time high annual current liabilities for Catalyst Biosciences?
Catalyst Biosciences all-time high annual total current liabilities is $101.23 M
What is Catalyst Biosciences quarterly total current liabilities?
The current quarterly current liabilities of CBIO is $1.78 M
What is the all time high quarterly current liabilities for Catalyst Biosciences?
Catalyst Biosciences all-time high quarterly total current liabilities is $101.23 M